Sotatercept Tied to Disease Modification in PAH

Data show sotatercept may deliver significant clinical benefits and could reshape the trajectory of this challenging disease.
Medscape Medical News

source https://www.medscape.com/viewarticle/996507?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?